tiprankstipranks
China Pharma Holdings (CPHI)
XASE:CPHI
US Market
CPHI
China Pharma Holdings
RESEARCH TOOLSreports

China Pharma Holdings (CPHI) Income Statement

275 Followers

China Pharma Holdings Income Statement

Last quarter (Q4 2025), China Pharma Holdings's total revenue was $1.23M, an increase of 8.11% from the same quarter last year. In Q4, China Pharma Holdings's net income was $-1.22M. See China Pharma Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 4.14M$ 4.53M$ 7.01M$ 8.10M$ 9.64M
Gross Profit
$ -131.95K$ -1.99M$ -281.08K$ -493.92K$ 349.27K
Operating Expenses
$ 2.96M$ 2.60M$ 2.47M$ 3.06M$ 3.21M
Depreciation and Amortization
$ 1.58M$ 2.62M$ 2.75M$ 2.70M$ 3.09M
EBITDA
$ -1.51M$ -1.96M$ 8.44K$ -837.69K$ 230.34K
Operating Income
$ -3.09M$ -4.59M$ -2.75M$ -3.55M$ -2.86M
Other Income/Expenses
$ -99.02K$ -147.50K$ -327.00K$ -423.86K$ -538.97K
Pretax Income
$ -3.19M$ -4.74M$ -3.08M$ -3.97M$ -3.40M
Net Income
$ -3.19M$ -4.74M$ -3.08M$ -3.97M$ -3.40M
Per Share Metrics
Basic EPS
$ -0.74$ -0.27$ -0.29$ -1.94$ -0.85
Diluted EPS
$ -0.74$ -0.27$ -0.29$ -1.94$ -0.85
Weighted Average Shares Outstanding
 4.29M 17.46M 10.60M 5.26M 4.61M
Weighted Average Shares Outstanding (Diluted)
 4.29M 17.46M 10.60M 5.26M 4.61M
Currency in USD

China Pharma Holdings Earnings and Revenue History